BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 7140544)

  • 1. [Parenteral pentoxifylline treatment of ischemic cerebrovascular accident. Preliminary results].
    Schneider R; Kiesewetter H
    Dtsch Med Wochenschr; 1982 Nov; 107(44):1674-7. PubMed ID: 7140544
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The rheological efficiency of parenteral pentoxifylline (Trental) in patients with ischemic brain lesions. Preliminary results.
    Schneider R; Schmid-Schönbein H; Kiesewetter H
    Eur Neurol; 1983; 22 Suppl 1():98-104. PubMed ID: 6884407
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Results of hemorheologically active treatment with pentoxifylline in patients with cerebrovascular disease.
    Schneider R
    Angiology; 1989 Nov; 40(11):987-93. PubMed ID: 2817522
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hemorheological disturbances in patients with chronic cerebrovascular diseases.
    Szapary L; Horvath B; Marton Z; Alexy T; Demeter N; Szots M; Klabuzai A; Kesmarky G; Juricskay I; Gaal V; Czopf J; Toth K
    Clin Hemorheol Microcirc; 2004; 31(1):1-9. PubMed ID: 15272148
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of dipyridamole plus pentoxifylline in patients with diffuse cerebrovascular insufficiency.
    Yayá R; Aznar J; Vayá A; Villa P; Santos T; Vallés J; Martinez-Sales V
    Thromb Haemost; 1985 Dec; 54(4):896. PubMed ID: 3911484
    [No Abstract]   [Full Text] [Related]  

  • 6. [Effect of vinpocetin on the hemorheologic parameters in patients with chronic cerebrovascular disease].
    Szapáry L; Horváth B; Alexy T; Márton Z; Késmárky G; Szóts M; Nagy F; Czopf J; Tóth K
    Orv Hetil; 2003 May; 144(20):973-8. PubMed ID: 12830727
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Clinical evaluation of the effects of pentoxifylline in patients with chronic peripheral circulatory disorders].
    Strano A; Davì G; Novo S; Avellone G; Pinto A
    Ric Clin Lab; 1981; 11 Suppl 1():303-11. PubMed ID: 7188117
    [No Abstract]   [Full Text] [Related]  

  • 8. A controlled trial of pentoxifylline (Trental 400) in intermittent claudication: clinical, haemostatic and rheological effects.
    Reilly DT; Quinton DN; Barrie WW
    N Z Med J; 1987 Jul; 100(828):445-7. PubMed ID: 3330188
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pentoxifylline -- a biomedical profile.
    Müller R
    J Med; 1979; 10(5):307-29. PubMed ID: 393789
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Hemocoagulation, fibrinolytic and rheologic parameters in ischemic vasculopathy. Effects of pentoxifylline in the treatment of acute cerebral vasculopathy].
    Muggeo M; Calabrò A; Businaro V; Patussi L; Volpe A; Signorini GP; Crepaldi G
    Ric Clin Lab; 1981; 11 Suppl 1():353-71. PubMed ID: 7188124
    [No Abstract]   [Full Text] [Related]  

  • 11. Effect of ethanol on hemorheology in patients with ischemic cerebrovascular disease and elderly healthy men.
    Nagai Y; Ishida K; Hirooka M; Nishimaru K
    Clin Hemorheol Microcirc; 2001; 25(3-4):135-44. PubMed ID: 11847416
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hemorheologic conditions in patients with cerebrovascular disease altered by treatment with pentoxifylline.
    Ott E; Lechner H
    Ric Clin Lab; 1981; 11 Suppl 1():253-6. PubMed ID: 7188113
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The role of haemorheological factors in the ageing brain: long-term therapy with pentoxifylline ('Trental' 400) in elderly patients with initial mental deterioration.
    Parnetti L; Ciuffetti G; Mercuri M; Lupattelli G; Senin U
    Pharmatherapeutica; 1986; 4(10):617-27. PubMed ID: 3602014
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of parenteral or oral vinpocetine on the hemorheological parameters of patients with chronic cerebrovascular diseases.
    Feher G; Koltai K; Kesmarky G; Horvath B; Toth K; Komoly S; Szapary L
    Phytomedicine; 2009 Mar; 16(2-3):111-7. PubMed ID: 19135345
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pentoxifylline and cerebrovascular diseases.
    Marcel GA; George C
    Eur Neurol; 1983; 22 Suppl 1():89-97. PubMed ID: 6350013
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The influence of I.V. application of pentoxifylline on the viscoelasticity of blood in patients with peripheral vascular disorders.
    Chmiel H; Anadere I; Heimburg P
    Ric Clin Lab; 1981; 11 Suppl 1():189-96. PubMed ID: 7188108
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [The course of hemorheologic parameters in acute cerebral ischemia].
    Lechner H; Ott E; Ossama N; Fazekas F
    Wien Med Wochenschr; 1986; 136 Spec No():47-9. PubMed ID: 3825171
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Chronic senile cerebrovascular insufficiency. Effects of suloctidil and pentoxifylline on erythrocyte deformability].
    Pilla G; Ciaponi A; Migliavacca A; Bonora C
    Ric Clin Lab; 1983; 13 Suppl 3():459-64. PubMed ID: 6324325
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cerebrovascular circulatory disorders: new aspects of pathophysiology and therapy.
    Müller R; Schröer R
    J Med; 1979; 10(5):347-64. PubMed ID: 393790
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Sudden deafness: apropos of 19 cases. Results of treatment with pentoxifylline. Value of erythrocyte filtration time].
    Denis F; Ketari M; Benzaken J; Renou G
    Ann Otolaryngol Chir Cervicofac; 1989; 106(1):21-6. PubMed ID: 2719437
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.